Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Open Access
- 16 February 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (2), e17217
- https://doi.org/10.1371/journal.pone.0017217
Abstract
HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors. Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/m2; p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)]. HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI.Keywords
This publication has 57 references indexed in Scilit:
- Cytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: A Prospective Observational Cohort StudyAmerican Journal of Epidemiology, 2010
- The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsAIDS, 2010
- Continuous antiretroviral therapy decreases bone mineral densityAIDS, 2009
- Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adultsAIDS, 2009
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on SurvivalNew England Journal of Medicine, 2009
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infectionAIDS, 2007
- The population burden of fractures originates in women with osteopenia, not osteoporosisOsteoporosis International, 2006
- Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent FracturesArchives of Internal Medicine, 2004